Publication Date
| In 2025 | 0 |
| Since 2024 | 0 |
| Since 2021 (last 5 years) | 0 |
| Since 2016 (last 10 years) | 0 |
| Since 2006 (last 20 years) | 2 |
Descriptor
| Adolescents | 2 |
| Children | 2 |
| Comparative Analysis | 2 |
| Drug Therapy | 2 |
| Epilepsy | 2 |
| Seizures | 2 |
| Age Differences | 1 |
| Anxiety Disorders | 1 |
| At Risk Persons | 1 |
| Attention Deficit Disorders | 1 |
| Attention Deficit… | 1 |
| More ▼ | |
Source
| Developmental Medicine &… | 2 |
Author
| Hermann, Bruce | 2 |
| Seidenberg, Michael | 2 |
| Caplan, Rochelle | 1 |
| Geary, Elizabeth | 1 |
| Jones, Jana | 1 |
| Jones, Jana E. | 1 |
| Koehn, Monica | 1 |
| Parrish, Joy | 1 |
| Seth, Raj | 1 |
| Sheth, Raj | 1 |
| Watson, Ryann | 1 |
| More ▼ | |
Publication Type
| Journal Articles | 2 |
| Reports - Research | 2 |
Education Level
Audience
Location
Laws, Policies, & Programs
Assessments and Surveys
What Works Clearinghouse Rating
Peer reviewed
Direct linkParrish, Joy; Geary, Elizabeth; Jones, Jana; Seth, Raj; Hermann, Bruce; Seidenberg, Michael – Developmental Medicine & Child Neurology, 2007
There is considerable interest in the assessment of executive function (EF) in pediatric clinical populations but only a few well-standardized measures exist. We examined EF in 53 children aged 8 to 18 years with recent onset epilepsy (31 males, 22 females) and 50 control children (23 males, 27 females) using the Behavior Rating Inventory of…
Descriptors: Epilepsy, Child Behavior, Cognitive Ability, Cognitive Processes
Jones, Jana E.; Watson, Ryann; Sheth, Raj; Caplan, Rochelle; Koehn, Monica; Seidenberg, Michael; Hermann, Bruce – Developmental Medicine & Child Neurology, 2007
The aim of this study was to characterize the distribution, timing, and risk factors for psychiatric comorbidity in children with recent onset epilepsy. Children aged 8 to 18 years with recent onset epilepsy (less than 1 year in duration) of idiopathic etiology (n=53) and a healthy comparison group (n=50) underwent a structured psychiatric…
Descriptors: Incidence, Neurological Organization, Drug Therapy, At Risk Persons
